Deep Genomics
Deep Genomics is a biotechnology company leveraging artificial intelligence to revolutionize drug development, especially in RNA therapies. They develop AI platforms to identify novel targets and therapeutic candidates for genetic conditions, aiming to program therapies for any gene and any genetic disorder. Their mission is to build a new kind of genetic medicine company that uses AI to discover and develop better treatments for rare genetic diseases.
Industries
Nr. of Employees
medium (51-250)
Deep Genomics
480 University Avenue, Suite 1300 Toronto, Ontario, Canada, M5G 1V2
Patents
Systems and methods for classifying, prioritizing and interpreting genetic variants and therapies using a deep neural network
US-11887696-B2
View DetailsMethods and systems for producing an expanded training set for machine learning using biological sequences
US-11769073-B2
View DetailsSystems and methods for generating and training convolutional neural networks using biological sequences and relevance scores derived from structural, biochemical, population and evolutionary data
US-11636920-B2
View DetailsNeural network architectures for scoring and visualizing biological sequence variations using molecular phenotype, and systems and methods therefor
US-11568960-B2
View Details
Systems and methods for classifying, prioritizing and interpreting genetic variants and therapies using a deep neural network
US-11887696-B2
View DetailsMethods and systems for producing an expanded training set for machine learning using biological sequences
US-11769073-B2
View DetailsSystems and methods for generating and training convolutional neural networks using biological sequences and relevance scores derived from structural, biochemical, population and evolutionary data
US-11636920-B2
View DetailsNeural network architectures for scoring and visualizing biological sequence variations using molecular phenotype, and systems and methods therefor
US-11568960-B2
View DetailsProducts
RNA foundation-model platform
Platform combining curated datasets, data-processing pipelines, and large-scale machine learning models trained to predict RNA regulatory biology, identify targets, and design RNA-targeting therapeutic candidates.
RNA foundation-model platform
Platform combining curated datasets, data-processing pipelines, and large-scale machine learning models trained to predict RNA regulatory biology, identify targets, and design RNA-targeting therapeutic candidates.
Services
Computational discovery service that identifies disease mechanisms, prioritizes genomic targets, and designs RNA-targeting therapeutic candidates using foundation-model-driven pipelines.
Partnership-driven programs providing sponsored genetic testing and support for aggregation of medical-record data to assist diagnosis confirmation and research recruitment.
Laboratory services to generate biological datasets and perform functional assays and in vivo testing to validate computationally designed therapeutic candidates and support translational decisions.
Computational discovery service that identifies disease mechanisms, prioritizes genomic targets, and designs RNA-targeting therapeutic candidates using foundation-model-driven pipelines.
Partnership-driven programs providing sponsored genetic testing and support for aggregation of medical-record data to assist diagnosis confirmation and research recruitment.
Laboratory services to generate biological datasets and perform functional assays and in vivo testing to validate computationally designed therapeutic candidates and support translational decisions.
Expertise Areas
- Foundation-model development for RNA biology
- Sequence-to-function prediction and variant effect analysis
- RNA-targeting therapeutic design (oligonucleotides, RNA editing, mRNA)
- Preclinical experimental validation and in vivo testing
Key Technologies
- RNA foundation models
- Deep learning for sequence-to-function prediction
- Next-generation sequencing (NGS)
- Single-cell genomics